ANTIBODIES TO PLATELET-ACTIVATING-FACTOR (PAF) INHIBIT PAF-INDUCED PLATELET-AGGREGATION

被引：0
|
作者：
SMAL, MA
COONEY, SJ
BALDO, BA
机构：
[1] ROYAL N SHORE HOSP,KOLLING INST MED RES,ST LEONARDS,NSW 2065,AUSTRALIA
[2] UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA
来源：
JOURNAL OF LIPID MEDIATORS | 1991年 / 4卷 / 03期
关键词：
PLATELET AGGREGATION; PLATELET-ACTIVATING FACTOR; ANTI-PAF;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Platelet-activating factor (PAF) is the most potent platelet agonist known. PAF-induced platelet aggregation was blocked by pre-incubation of PAF with the immunoglobulin fraction from sheep or rabbit anti-PAF anti-serum. Inhibition was specific for PAF and was dependent upon immunoglobulin and PAF concentrations. Antibody-mediated inhibition of PAF-activity may be a valuable method for studying the biological effects of PAF in some systems.
引用
收藏
页码：333 / 341
页数：9
相关论文
共 50 条
  • [21] ALBUMIN INHIBITS PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED RESPONSES IN PLATELETS AND MACROPHAGES - IMPLICATIONS FOR THE BIOLOGICALLY-ACTIVE FORM OF PAF
    GRIGORIADIS, G
    STEWART, AG
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (01) : 73 - 77
  • [22] A COMPETITIVE RECEPTOR-BINDING ASSAY FOR PLATELET-ACTIVATING-FACTOR (PAF) - QUANTIFICATION OF PAF IN RAT-BRAIN
    TIBERGHIEN, C
    LAURENT, L
    JUNIER, MP
    DRAY, F
    JOURNAL OF LIPID MEDIATORS, 1991, 3 (03): : 249 - 266
  • [23] Inhibition of platelet-activating factor (PAF)-induced platelet aggregation by fatty acids from human saliva
    Smal, Mary A.
    Baldo, Brian A.
    PLATELETS, 2022, 33 (04) : 562 - 569
  • [24] PLATELET-ACTIVATING-FACTOR (PAF) CONCENTRATION AND PAF ACETYLHYDROLASE ACTIVITY IN CEREBROSPINAL-FLUID OF PATIENTS WITH SUBARACHNOID HEMORRHAGE
    HIRASHIMA, Y
    ENDO, S
    OHMORI, T
    KATO, R
    TAKAKU, A
    JOURNAL OF NEUROSURGERY, 1994, 80 (01) : 31 - 36
  • [25] INHIBITION OF EXVIVO PAF-INDUCED PLATELET-AGGREGATION BY THE PAF-ANTAGONIST RP-48740 - RELATIONSHIP TO PLASMA-CONCENTRATIONS IN HEALTHY-VOLUNTEERS
    PINQUIER, JL
    SEDIVY, P
    BRUNO, R
    BOMPART, F
    GREGOIRE, J
    STRAUCH, G
    GAILLOT, J
    CLUCAS, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (02) : 141 - 145
  • [26] RAPID AND SELECTIVE MEASUREMENT OF PLATELET-ACTIVATING-FACTOR USING A QUANTITATIVE BIOASSAY OF PLATELET-AGGREGATION
    AMMIT, AJ
    ONEILL, C
    JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 26 (01): : 7 - 21
  • [27] PLATELET-ACTIVATING-FACTOR (PAF) AND THE FORMATION OF CHRONIC SUBDURAL-HEMATOMA - MEASUREMENT OF PLASMA PAF LEVELS AND ANTI-PAF IMMUNOGLOBULIN TITERS
    HIRASHIMA, Y
    ENDO, S
    HAYASHI, N
    KARASAWA, K
    NOJIMA, S
    TAKAKU, A
    ACTA NEUROCHIRURGICA, 1995, 137 (1-2) : 15 - 18
  • [28] A NOVEL CLASS OF PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS .1. SYNTHESIS AND STRUCTURE ACTIVITY STUDIES ON PAF-SULFONAMIDE ISOSTERES
    TSURI, T
    HAGA, N
    MATSUI, T
    KAMATA, S
    KAKUSHI, H
    UCHIDA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (01) : 75 - 84
  • [29] ROLE OF ENDOGENOUS PLATELET-ACTIVATING-FACTOR (PAF) IN ENDOTOXIN-INDUCED PORTAL-HYPERTENSION IN RATS
    KITAGAWA, S
    KUBOTA, Y
    YAMAGUCHI, T
    FUJIMURA, K
    BINNAKA, T
    TANI, K
    OGURA, M
    MIZUNO, T
    INOUE, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1992, 7 (05) : 481 - 485
  • [30] THE LYSO-PRECURSOR OF PLATELET-ACTIVATING-FACTOR (LYSO-PAF) IN ISCHEMIC MYOCARDIUM
    LEONG, L
    STURM, M
    TAYLOR, R
    JOURNAL OF LIPID MEDIATORS, 1991, 4 (03): : 277 - 287
12345